Dermatological Treatments for Psoriasis and Skin Disorders Exempt from GST: Kerala AAR Clarifies

Introduction

In a significant ruling for the healthcare sector, the Kerala Authority for Advance Ruling (AAR) has affirmed that treatments for dermatological conditions such as psoriasis, dandruff, dermatitis, anti-fungal infections, and folliculitis qualify for exemption from Goods and Services Tax (GST). The decision, issued on November 24, 2025, in the case of M/s. Advanced Hair Restoration India Private Limited , underscores the applicability of Sl. No. 74 of Notification No. 12/2017–Central Tax (Rate) dated June 28, 2017, to genuine medical interventions for skin ailments. The bench, comprising Shri. Jomy Jacob IRS and Shri. Mansur.M. I, emphasized that these services constitute "healthcare services" provided by a recognized clinical establishment, distinguishing them from purely cosmetic procedures. This clarification comes at a time when GST compliance remains a critical concern for medical clinics, particularly those dealing with specialized treatments, and integrates seamlessly with broader discussions on tax relief for essential health services as highlighted in recent industry analyses.

The ruling addresses a query from the applicant, a Kochi-based company operating skin clinics across Kerala, which sought confirmation on the tax-exempt status of its services. By granting the exemption, the Kerala AAR provides much-needed certainty, potentially influencing similar establishments nationwide and alleviating financial burdens on patients seeking treatment for chronic skin conditions.

Case Background

M/s. Advanced Hair Restoration India Private Limited, with its principal place of business at KNA Plaza, Ernakulam Bypass, Maradu, Ernakulam, Kerala, specializes in healthcare services encompassing skin treatments, dental care, and hair restoration. Established as a clinical entity, the company employs approximately 80 qualified medical professionals, including dermatologists, medical officers, and dental surgeons, all approved by the Health Services Department. These experts, supported by paramedical staff like nurses, deliver treatments at multiple centers across the state.

The legal dispute—or rather, the seek for advance ruling—arose from the applicant's need to confirm the GST implications of its core services. Specifically, the company provides diagnosis, treatment, and care for conditions like psoriasis (a chronic autoimmune skin disease), dandruff, dermatitis (inflammation of the skin), anti-fungal treatments for infections, and folliculitis (inflammation of hair follicles). These services are rendered under medical prescriptions following consultations, pathological tests, and patient consents, with comprehensive records maintained for each case.

The applicant holds necessary licenses, including paramedical licenses from the Health Department and IFTE (Infectious Diseases Hospital Trade Establishment) and OS (Occupation and Service) licenses under Section 447 of the Kerala Municipality Act, issued by bodies like the Kochi Municipal Corporation. These licenses classify the establishments as "skin clinics," aligning with statutory requirements for clinical operations.

The advance ruling application, filed under Section 97 of the Central Goods and Services Tax (CGST) Act, 2017, with ARN AD3210240061034, posed a single key question: Whether exemption from GST is available on these healthcare services in accordance with Notification No. 12/2017–Central Tax (Rate). The jurisdictional officer reported no ongoing or prior proceedings on the issue, paving the way for the AAR's examination. A personal hearing was conducted virtually on August 8, 2025, where Advocate K.N. Sreekumar represented the applicant, submitting additional documents like consultation forms, invoices, and professional guidelines from the Indian Association of Dermatologists.

This case is timely, as the GST regime since 2017 has exempted most healthcare services to promote accessibility, but ambiguities persist regarding specialized treatments. The timeline reflects efficiency: application in 2024, hearing in 2025, and ruling by late 2025, highlighting the AAR's role in preemptive tax guidance.

Arguments Presented

The applicant's contentions centered on establishing the medical and statutory credentials of its services. They argued that their operations fully qualify as a "clinical establishment" under para 2(s) of Notification No. 12/2017, defined as any institution providing diagnosis, treatment, or care for illness, injury, deformity, abnormality, or pregnancy in a recognized system of medicine. The company emphasized its employment of licensed dermatologists and medical officers, who conduct thorough examinations, prescribe treatments, and monitor progress, all documented in patient records, invoices, and consent forms.

Further, the applicant asserted that the services fall under "healthcare services" as per para 2(zg) of the notification, which encompasses diagnosis or treatment for illness or abnormality, excluding only hair transplants or cosmetic/plastic surgery unless restorative. They provided evidence of treating genuine medical conditions—psoriasis as an autoimmune disorder, dermatitis as inflammatory, and infections as pathological—rather than aesthetic enhancements. Sample documents, including hair transplant consultation forms (clarified as non-applicable to the query), pathological reports, and invoices specifying the attending doctor's name and treatment nature, were submitted to demonstrate bona fides.

The applicant also referenced professional endorsements from the Indian Association of Dermatologists, reinforcing that these are standard dermatological interventions. They highlighted compliance with local licenses describing their business as "skin clinics" or "personal care" sub-type "hair fixing," but stressed that the ruling query focused solely on therapeutic skin treatments, not cosmetic hair procedures. In their additional submission post-hearing, they clarified the term "exigible" in the question meant "eligible for exemption," underscoring the non-cosmetic intent.

On the other side, the jurisdictional officer's comments were neutral and procedural. As per Section 98(1) of the CGST Act, the officer confirmed that the issue was neither pending nor decided in any proceedings under the Act, providing no substantive opposition. This lack of contention from tax authorities allowed the AAR to focus on interpretive analysis without adversarial factual disputes. The applicant prayed for a favorable ruling, arguing that denying exemption would undermine the intent of GST relief for essential healthcare, potentially increasing costs for patients with chronic conditions.

Legal Analysis

The Kerala AAR's reasoning hinged on a meticulous interpretation of Notification No. 12/2017–Central Tax (Rate), particularly Sl. No. 74, which exempts "healthcare services by a clinical establishment, an authorised medical practitioner or para-medics." The authority dissected the definitions: "clinical establishment" (para 2(s)) requires provision of diagnosis or treatment in a recognized medical system, which the applicant's licensed skin clinics satisfied through statutory approvals and professional staffing. Similarly, "healthcare services" (para 2(zg)) demand services for illness or abnormality, explicitly excluding non-restorative cosmetic procedures.

The bench affirmed that psoriasis, dandruff, dermatitis, anti-fungal infections, and folliculitis are recognized medical conditions—psoriasis as a chronic autoimmune illness, others as inflammatory or infectious abnormalities—necessitating clinical intervention. Treatments involved diagnosis via consultations and tests, followed by therapeutic care, evidenced by records showing medical oversight, not mere beautification. This distinguished the services from excluded categories like hair transplants, noted in the applicant's documents but irrelevant to the query.

A key precedent cited was the Maharashtra AAR's ruling in M/s. Jyothi Ceramic Industries Pvt. Ltd. , which held that cosmetic services for aesthetic enhancement do not qualify as healthcare unless restoring anatomy affected by defects, injury, or trauma. The Kerala AAR applied this to caution that while the queried treatments exempt, any unrelated cosmetic hair fixing (as per the Thiruvalla license) would not. This precedent reinforced the exclusionary scope, ensuring exemptions align with public health policy rather than commercial aesthetics.

The analysis clarified distinctions: quashing-like scrutiny isn't applicable here, but interpretive boundaries between therapeutic (exempt) and cosmetic (taxable) care are crucial. Societal impact was implicit—exemptions reduce patient costs for prevalent skin disorders affecting millions, promoting equity. No direct invocation of CGST sections beyond Section 97(2)(e) for admissibility, but the ruling invoked the notification's broad "healthcare" ambit, accommodating dermatology under recognized allopathic systems.

Integrating external context, recent clarifications from tax bodies, such as those on beauty parlors versus clinics, align with this decision, emphasizing medical necessity over appearance. The AAR's holistic view—balancing evidence, definitions, and policy—ensures the exemption's robustness.

Key Observations

The judgment extracts several pivotal excerpts that illuminate the court's reasoning:

• On the definition of healthcare services: “ ‘healthcare services’ means any service by way of diagnosis or treatment or care for illness, injury, deformity, abnormality, or pregnancy in any recognized system of medicine in India, and includes transportation of the patient to and from a clinical establishment, but does not include hair transplant or cosmetic or plastic surgery, except when undertaken to restore or reconstruct anatomy or functions of the body affected due to congenital defects, developmental abnormalities, injury, or trauma.” This foundational quote establishes the threshold for exemption, emphasizing medical over aesthetic intent.

• Regarding clinical establishments: “ ‘clinical establishment’ as a hospital, nursing home, clinic, sanatorium, or any other institution by whatever name called, that provides services or facilities requiring diagnosis or treatment or care for illness, injury, deformity, abnormality, or pregnancy in any recognized system of medicine in India.” The authority highlighted how the applicant's licenses as "skin clinics" fit this, attributing the observation to the statutory framework.

• On the nature of the treatments: “These are well-recognized medical conditions in dermatology. Psoriasis, for example, is a chronic autoimmune skin disease requiring long-term treatment. Similarly, dermatitis, fungal infections, and folliculitis are medically recognized conditions that require professional diagnosis and treatment.” This underscores the therapeutic classification, directly from the discussion section.

• Distinguishing from cosmetics: “The treatments provided are not merely cosmetic in nature but involve clinical diagnosis and therapeutic care. The applicant has produced consultation forms, prescriptions, and diagnostic reports, which evidence that patients are examined by qualified medical officers or dermatologists before commencing treatment.” This quote addresses potential ambiguities, reinforcing evidence-based exemption.

• Precedent application: Referencing Maharashtra AAR, “cosmetic services not aimed at restoring or reconstructing the anatomy or function of the human body affected by such conditions are to be treated as purely cosmetic.” This borrowed observation clarifies boundaries, preventing overreach.

These observations, properly attributed to the AAR's detailed analysis, highlight the ruling's precision and evidentiary grounding.

Court's Decision

The Kerala AAR unequivocally ruled in favor of the applicant: "Yes. The healthcare services provided by the applicant in connection with the treatment of psoriasis, dandruff, dermatitis, anti-fungal infections, folliculitis, and similar dermatological conditions are exempted under Sl. No. 74 of Notification No. 12/2017–Central Tax (Rate) dated 28.06.2017."

The decision ordered no GST levy on these specified services, confirming the applicant's eligibility as a clinical establishment delivering bona fide healthcare. Practically, this means the company can continue claiming exemptions on service charges, supported by invoices and records detailing medical involvement, without fear of retrospective demands.

Implications are far-reaching: For dermatology clinics and similar entities, it provides binding precedent (under Section 103 of the CGST Act) within Kerala, potentially influencing other states' AARs toward uniformity. Patients benefit from lower costs, as GST (typically 18% on non-exempt services) would otherwise inflate bills for chronic treatments. Future cases may cite this to argue exemptions for other specialized care, like allergy treatments, but must navigate the cosmetic exclusion—e.g., hair transplants remain taxable unless restorative.

Broader effects include bolstering GST's pro-health policy, reducing compliance burdens for small clinics, and encouraging investment in medical dermatology. However, practitioners must maintain robust documentation to differentiate therapeutic from aesthetic services, avoiding audits. This ruling, amid evolving tax jurisprudence, reinforces that GST exemptions prioritize public welfare, impacting legal practice by guiding advisory roles in healthcare taxation.